logo
Questions? +1 (202) 335-3939 Login
Set Up FREE Account Submit Release
Trusted News Since 1995
A service for pharmaceutical industry professionals · Friday, May 9, 2025 · 810,975,925 Articles · 3+ Million Readers
Home  •••  Newswires by Industry  •  Countries  •  U.S. States  •  World Media Directory
Pharmaceutical Industry News  •••  Topics  •  Countries  •  U.S. States

Drugmakers Profits News Monitoring

  • Published on May 8, 2025

    Japanese Pharma Company Takeda Expects Limited Exposure To US-China Tariffs

    Takeda Pharmaceutical Company Limited TAK reported a fiscal year 2024 net profit of 107.9 billion yen (around $709.86 million), down 25.1% year over year. Core net profit increased 2.5% (down 3.4% at constant currency) to 775.6 billion yen. Takeda CEO …

    Source: Benzinga - Neutral
  • Published on May 8, 2025

    Takeda FY24 Net Profit Down; Lifts Dividend; Sees Higher Profit, But Weak Sales In FY25; Stock Down

    Takeda Pharmaceutical Company Ltd. (TAK) Thursday reported lower net profit in its fiscal 2024, while profit before tax surged from last year with growth in revenues. Further, the company lifted dividend, and said it projects higher profit for fiscal 2025, …

    Source: RTTNews - Neutral
  • Published on May 8, 2025

    Novavax swings to profit, says talks with FDA on COVID vaccine approval ongoing

    Audio By Carbonatix (Reuters) -Novavax said on Thursday discussions with the U.S. health regulator on its COVID-19 shot are ongoing and a pathway to approval will be clear as soon as the vaccine maker and the regulator agree on the parameters of a post- …

    Source: SRN News - Center-right
  • Published on May 8, 2025

    Novavax swings to profit on lower expenses related to COVID shots

    (Reuters) – Novavax on Thursday swung to a first-quarter profit from a year-ago loss, helped by reduced costs related to the development and sale of its COVID-19 vaccines, its only product on the market. Shares of the company rose 8.74% to $6.47 in …

    Source: KFGO - North Dakota - Neutral
  • Published on May 7, 2025

    Novo Nordisk shares pop as drugmaker sees copycat Wegovy sales easing in 2025

    Flags with the logos of Danish drugmaker Novo Nordisk, maker of the blockbuster diabetes and weight-loss treatments Ozempic and Wegovy are pictures while the company presents the annual report at Novo Nordisk in Bagsvaerd, Denmark, on February 5, 2025.  …

    Source: CNBC - Neutral
  • Published on May 8, 2025

    We Need Progress, Not Just The Progress Congress Will ‘Pay For’

    CHICAGO - JULY 23: Lipitor tablets sit in a tray at a Pharmacy July 23, 2008 in Chicago, Illinois. ... More Pfizer, the world's biggest drug maker and manufacturer of the cholesterol drug Lipitor, said today its second quarter profit rose to $2.78 …

    Source: Forbes - Neutral
  • Published on May 7, 2025

    Europe close: Stocks decline as Fed jitters prompt profit-taking

    The Stoxx 600 fell 0.5% to 533.47 with most major indices across the continent registering losses by the close of trade. Even after the losses of the past two days, the index is still up 12.5% over the month following a strong rebound after the initial …

    Source: ShareCast - Neutral
  • Published on May 7, 2025

    Teva Jumps On Outlook As CEO Touts 'Real Clarity' On Profits

    Teva stock bumped into its 200-day line Wednesday after the drugmaker beat first-quarter profit expectations and raised its earnings outlook for the year. For the year, Teva Pharmaceutical (TEVA) now expects to earn $2.45 to $2.65 a share, on an adjusted …

    Source: Investor's Business Daily - Neutral
  • Published on May 7, 2025

    Wegovy maker Novo Nordisk cuts profit forecast as US prescriptions tail off

    Denmark’s Novo Nordisk has cut its annual revenue and profit forecasts after disappointingly “flabby” sales of its weight loss drug Wegovy, as US prescriptions tailed off amid fierce competition. A boom in sales of Wegovy and the diabetes medication …

    Source: The Guardian - Center-left
  • Published on May 7, 2025

    Teva beats on profit, misses on revenue

    Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) today published its first quarter 2025 financial results and revised its 2025 guidance with lower revenue but higher profit. The Israeli pharmaceutical company now expects $16.8-17.2 billion …

    Source: Globes - Pending
  • Published on May 7, 2025

    Teva Pharmaceutical's branded drugs boost first quarter profit

    By Steven Scheer JERUSALEM (Reuters) - Teva Pharmaceutical Industries reported a larger than expected rise in first-quarter profit, helped by strong sales gains for a trio of its branded drugs treating migraines, Huntington's disease and schizophrenia. …

    Source: The Gazette - Colorado - Neutral
  • Published on May 7, 2025

    Weight-loss drugmaker Novo Nordisk slims sales forecast

    Danish drugmaker Novo Nordisk, known for its blockbuster diabetes and weight-loss treatments Ozempic and Wegovy, cut its annual sales forecast on Wednesday, citing a decline in its US market share. Novo Nordisk blamed the revised outlook on competition …

    Source: RTL Today - Neutral
  • Published on May 7, 2025

    Teva Pharm first-quarter profit rise tops estimates

    JERUSALEM (Reuters) -Teva Pharmaceutical Industries reported a slightly larger than expected rise in first-quarter profit, helped by strong sales gains in a trio of its branded drugs to treat migraines, Huntington's disease and schizophrenia. The world …

    Source: Yahoo Finance - Pending
  • Published on 05:23 GMT

    LIVE earnings season blog - Nintendo, News Corp + more

    Welcome to our live blog coverage of earnings season! This is the time of year when publicly traded companies report their financial results, giving investors and analysts a glimpse into their performance and future outlook. We'll bring you real-time …

    Source: Azzet - Pending
  • Published on 05:06 GMT

    SK biopharmaceuticals' Q1 earnings solid on strong US cenobamate sales

    SK biopharmaceuticals on Friday released robust financial results for the first quarter of 2025, driven by sustained growth in U.S. sales of its epilepsy treatment cenobamate, marketed as Xcopri. The company posted revenue of 144.4 billion won ($102.4 …

    Source: Korea Biomedical Review - Neutral
  • Published on 04:56 GMT

    Delivering Lower Rx Prices for the American People

    “For generations, the American people have been abused by Big Pharma.” President Trump said those words during his first administration, and it still reins true to this day as the White House recently elevated the importance of policies to stop Americans …

    Source: Townhall - Right-wing
  • Published on 01:17 GMT

    3 Smallcap stocks where aggressive FII activity could signal opportunity

    During the fourth quarter of the financial year 2025, Indian markets witnessed one of the highest sales in the equity segment by the Foreign Institutional Investors (FIIs). They offloaded equities worth ₹1,16,559 crore in just three months. While this has …

    Source: Financial Express - Neutral
  • Published on 02:12 GMT

    Popular hair loss drug linked to suicidal thoughts, sparking FDA and EU warnings

    The EMA confirms finasteride (Propecia/Proscar) can cause suicidal thoughts, adding to known sexual and psychiatric side effects, despite being marketed as safe for hair loss. Finasteride, originally for prostate treatment, blocks DHT to slow balding …

    Source: Natural News - Right-wing
  • Published on May 8, 2025

    Key lawmaker seeks to cap insulin prices at $35 a month

    Tabitha Mueller The Nevada Independent CARSON CITY — Assembly Speaker Steve Yeager introduced a bill on Thursday to cap the price of insulin drug copays to $35 a month for Nevadans on private insurance — a measure that could have major implications for …

    Source: Elko Daily Free Press - Nevada - Pending

03 days 22:10:44

Featured Releases

Got News to Share? · Submit · See All
Got news to share? Submit it now.
Load more pharmaceuticals news or search news using your own keywords. There are 810,975,925 articles in our news database.

Online News Monitoring Made Simple

Established in 1995, EIN Newsdesk helps millions of users track breaking news across thousands of trusted websites. Users may set up custom email newsletters and RSS feeds or search among thousands of preset news sections. As a member, you may also submit your own news using the EIN Presswire distribution service. Membership is free and we do not sell or lease any information about you. Press release distribution, dedicated APIs, and custom services generate the revenue that allow us to offer you free basic access.

News by Country & by Industry

Worldwide News Coverage

Track news across more than 5,000 sources by country or industry or search our real-time news index.

Pharmaceutical Industry News by Country >
Pharmaceutical Industry News by U.S. State >
Pharmaceutical Industry News Topics >
Online News Publications >
World News Report >

News Alerts & News Feeds

Custom News Monitoring

News page results can be outputted as RSS or received daily by email. You may also use our NewsPlugin for WordPress.

Create Email Newsletter >
Create RSS Feed >
NewsPlugin for WordPress >

Submit News

PR Distribution Service

Our EIN Presswire's distribution footprint reaches millions. You can upload news which is re-published through EIN Newsdesk, fed into Twitter and Facebook, and onto partner sites, Google News, Bing News, etc.

EIN Presswire >
Events >

World Media Directory

News Media Guide

This is a listing of the world’s TV stations, radio stations, newspapers, and blogs. Last update: 04/18/2025

World Media Directory >

Healthcare & Pharmaceuticals Industry Press Releases

Got News to Share? · Submit · See All
Got news to share? Submit it now.

Healthcare & Pharmaceuticals Events

See All

No event was found.

Become a Member - Join Today!
Join thousands of professionals. Stay current. Stay competitive.
  • Track news from thousands of sources
  • Submit news sources for inclusion in our news tracking algorithm
  • Build your own customized email newsletters
  • Use of our RSS Feeds
  • Includes a complimentary EIN Presswire account plus 1-free release
  • Uncluttered & advertising free news pages

Pharmaceutical Industry Today by EIN Newsdesk & EIN Presswire (a press release distribution service)

Follow us on Facebook and connect with us on LinkedIn

Newsmatics Inc., 1025 Connecticut Avenue NW, Suite 1000, Washington, DC 20036 · Contact · About

© 1995-2025 Newsmatics Inc., a publisher of EIN News · All Rights Reserved · Privacy Policy · User Agreement